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ABSTRACT
K+-INDUCED SMOOTH MUSCLE CALCIUM SENSITIZATION
REQUIRES RHOA KINASE (ROK) TRANSLOCATION TO
CAVEOLAE WHICH IS INHIBITED IN NON-NEURONAL CELL
MEMORY
Nicole Hairrell Urban
Old Dominion University and Eastern Virginia Medical School, 2000
Chair: Dr. Paul H. Ratz

KC1 causes sm ooth muscle contraction by elevating intracellular free calcium
([Ca 2+]i), while receptor stimulation activates an additional mechanism termed Ca2+sensitization that can involve activation of ROK and PKC. However, recent studies
support the hypothesis that KC1 may also increase Ca2+-sensitivity (36). Our data showed
that the PKC inhibitor, GF-109203X, did not, while the ROK inhibitor, Y-27632, did
inhibit KCl-induced tonic (5’) force and myosin light chain (MLC) phosphorylation in
rabbit artery. Y-27632 also inhibited Bay K-8644- and ionomycin-induced MLC
phosphorylation and force, but did not inhibit KCl-induced calcium entry or peak (~15”)
force. Moreover, KC1 and Bay K-8644 nearly doubled the amount o f ROK colocalized to
caveolae at 30”, a time that preceded inhibition o f force by Y-27632. Colocalization was
not inhibited by Y-27632, but was abolished by nifedipine and the calmodulin blocker,
trifluoperazine. Since, -30% o f RhoA is colocalized with caveolin basally, these data
suggest a novel model for Ca2+-activated Ca2+-sensitization, elicited by KC1 contraction,
that involves Ca2+/cam dependent ROK translocation to caveolae and activation by
RhoA.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Our laboratory previously showed that the degree of force produced for a given
KCl-induced increase in [Ca2+]i can be substantially altered by the history o f receptor
stimulation termed “non-neuronal cell memory”, because the vascular smooth muscle
cells stored information temporarily about the degree o f prior activation (75). PE
pretreatment inhibited o f ROK translocation to caveolae in the subsequent KC1
contraction and caused an increase in inactive RhoA. PKG activation also caused a
similar inhibition of the RhoA/ROK signaling pathway. Ca2+-desensitization elicited by
PP1 inhibition caused caveolar internalization and inhibited o f ROK translocation. PKG
was also found to cause caveolar internalization, supporting the hypothesis that caveolar
maintenance is kinase-mediated. These data support the hypothesis that the information
storage method utilized in non-neuronal cell memory involves an inhibition o f the
RhoA/ROK pathway. Moreover, these data support the hypothesis that caveolae are loci
for signal transduction pathways, and suggest that the membranous location o f caveolae
is an important factor in RhoA/ROK-mediated Ca2+-sensitization.
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TERM OR ABREV.

DEFINITION

Ca2+

calcium

[Ca2+]j

intracellular free calcium

MLC

myosin light chain

RLC

regulatory light chain o f myosin II

PKC

protein kinase C

PLC

phospholipase C

PIP 2

phosphatidylinositol-4,5-bis-phosphate

IP 3

inositol-1,4,5-trisphosphate

DAG

1,2 -diacylglycerol

CPI-17

protein kinase C-potentiated inhibitory protein

MYPT1

myosin phosphatase targeting subunit

RHOA

small GTPase involved in Ca2+-sensitization

RHOGDI

guanine nucleotide dissociation inhibitor o f RhoA

GEF

guanine nucleotide nucleotide exchange factor

GAP

GTPase accelerating protein

ROK

RhoA kinase, effector o f RhoA

cAMP

cyclic adenosine monophosphate

PKA

protein kinase A

cGMP

cyclic guanosine monophosphate

PKG

protein kinase G

NO

nitric oxide
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EGF

epidermal growth factor

eNOS

endothelial nitric oxide synthase

LSM

laser scanning (confocal) microscope

PMT

photomultiplier tube

CAM

calmodulin

KC1

potassium chloride, depolarizes and contracts smooth muscle

PE

phenylephrine, a-adrenergic agonist

PT

phentolamine, a-adrenergic antagonist

Y-27632

ROK inhibitor

HA-1077

ROK inhibitor

GF-109203X

PKC inhibitor

NIFEDIPINE

L-type calcium channel inhibitor

BAY K-8644

L-type calcium channel agonist

IONOMYCIN

calcium ionophore

TFP

trifluoperazine, calcium/calmodulin inhibitor

8 BR-cGMP

cell permeable activator of PKG

PP1

protein phosphatase 1

OA

okadaic acid, PP1 inhibitor

NAF

sodium fluoride, PP1 inhibitor
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CHAPTER I
INTRODUCTION
An abnormal state o f increased contraction o f vascular smooth muscle is thought
to play a role in hypertension, coronary and cerebral vasospasm and vascular smooth
muscle cell proliferation (1). Recent studies suggest that the small GTPase RhoA and its
effector RhoA kinase (ROK) play a major role in the regulation o f vascular smooth
muscle contraction by modulating the Ca2+-sensitivity o f myosin II. Ca 2+-sensitization,
via the RhoA/ROK signaling pathway involves the inhibition o f myosin light chain
(MLC) phosphatase, the protein responsible for dephosphorylating the regulatory light
chain o f myosin II, which leads to the tonic (sustained contraction) phase o f agonistinduced contractions (1). A further understanding o f the mechanisms leading to Ca2+sensitization o f smooth muscle is an important step in the development o f treatments for
vascular diseases.

This dissertation follows the style o f Circulation Research.
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CHAPTER II

ORGANIZATION AND CONTRACTION IN MUSCLE
II. 1 Skeletal Muscle
The organization and contractile process o f smooth muscle is quite different than
that of skeletal muscle. Skeletal muscle is composed o f bundles o f multinucleated cells
organized into fibers comprised o f successively smaller subunits. Skeletal muscle fibers
have a bandlike pattern due to a highly organized subcellular structure which led to the
term striated muscle. The striated pattern o f skeletal muscle is due to the repeating
pattern o f two sets o f filaments in the bundles. The sarcomere is the basic unit o f skeletal
muscle structure which extends from one Z-line to the next and is composed o f myosin
fibers called thick filaments and actin fibers called thin filaments. The thin filaments
attach to Z-lines and partially interdigitate into the myosin filaments giving the myofibril
its alternating dark and light bands (2 ).
The thin filament is composed o f two actin filaments wound in an a-helix. One
strand o f tropomyosin is loosely associated with the actin backbone and is thought to
cover the active sites on actin. Troponin is a complex of three proteins that participates
in the control of skeletal muscle contraction. The complex is composed o f one subunit of
each troponin I, which has a strong affinity for actin; troponin T, which has an affinity for
tropomyosin; and troponin C which binds calcium (Ca2+) ions.
Each myosin molecule, or thick filament, is composed o f one set o f two heavy
chains (~200kDA each) and two sets o f light chains (~20kDa each). The C-terminal of
each heavy chain forms a long a-helical tail, and the two tails associate to form a lefthanded coiled coil. The N-terminal half o f each heavy chain has a globular tertiary
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structure, called the head region, which contains the actin binding domain and the ATPbinding site. A flexible neck region is located between the head and tail regions and
contains two calmodulin-like light chains. Several hundred myosin molecules aggregate
to form the thick filament. The tails are packed in a bipolar staggered array where the
heads protrude from each end and the center is a bare zone. The protruding head regions
o f the filaments, called crossbridges, link adjacent thin and thick filaments.
In skeletal muscle, an action potential in the cell membrane causes the Ca2+
concentration in the intracellular space to rise. Ca binding to troponin causes a thin
filament conformational change revealing the binding site for myosin on actin and allows
the proteins to interact. As Ca2+ is removed from the intracellular space and dissociates
from troponin, the thin filament returns to its original conformation and contraction
ceases (3). The myosin heavy chain is an ATPase that hydrolyzes ATP to ADP and Pi to
power muscle contraction. Briefly, the binding o f ATP to myosin results in the
dissociation o f actin and myosin. The ATP is rapidly hydrolyzed to form myosin-ADPPi, which is the “high energy” conformation o f myosin wherein the myosin head

undergoes a conformational change and becomes “cocked.” Next myosin-ADP- Pj
weakly binds actin, and a release o f Pj causes a stronger binding o f myosin-ADP to actin.
Subsequent release of ADP is the “power stroke” because myosin returns to its original
conformation while still bound to actin. Myosin can then undergo another round o f ATP
hydrolysis. This describes the “walking” o f myosin up the actin filament, and the
sequential binding and release o f actin by myosin results in muscle contraction.
Therefore, in skeletal muscle, unlike smooth muscle, the activation o f troponin by Ca2+ is
necessary and, in the presence o f ATP, sufficient to cause contraction.
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II.2 Smooth Muscle
Smooth muscle cells are usually 20 to 500 gm in length and two to five pm in
diameter and lack the striated appearance o f skeletal muscle cells. There are two types of
smooth muscle; multi-unit and unitary smooth muscle. Multi-unit smooth muscle is
similar to skeletal muscle in that each cell can act independently and can be innervated by
a single nerve ending. Multi-unit smooth muscle exists in the ciliary muscle o f the eye
and in the nictitating membrane in some lower animals, and is mainly controlled by
nervous signals. In unitary smooth muscle, the fibers are aggregated into bundles or
sheets and hundreds to thousands o f muscle fibers contract together. Unitary smooth
muscle, also called syncytial or visceral smooth muscle, is found in the vasculature and in
the walls o f most viscera o f the body such as urinary bladder, gut, ureters and uterus.
Gap junctions join adjacent cells so that ions can flow from one cell to another.
Intercellular protein bridges exist between the dense bodies, which serve the same
function as the Z lines in skeletal muscle, to allow for force transmission from one cell to
another. Actin filaments are attached to dense bodies, some o f which anchor the
cytoskeleton to the cell membrane. The interaction o f actin and myosin governs smooth
muscle contraction, but the troponin complex requisite for skeletal muscle contraction is
absent in smooth muscle (3).
Whereas skeletal muscle contraction which is governed by membrane potential
control and the binding o f calcium to a troponin, smooth muscle is not only regulated by
a similar electromechanical coupling, but also by pharmomechanical coupling (4).
Contractile stimuli cause an increase in intracellular free calcium ([Ca2+];) from both
extracellular stores, via non-specific cation channels and L-type voltage operated
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channels, and intracellular stores (sarcoplasmic reticulum). This increase in [Ca2+]j
causes an increase in Ca2+ binding to calmodulin which results in activation o f myosin
light chain (MLC) kinase. MLC kinase phosphorylates the myosin 20kDa regulatory
light chain (RLC). Smooth muscle MLC kinase is composed o f a kinase catalytic core
94 -

and a regulatory segment containing both a Ca /calmodulin-binding sequence and an
autoinhibitory segment. The autoinhibitory sequence prevents the binding o f RLCs but
94 -

not ATP. When activated by Ca , calmodulin binds to MLC kinase at the
9 I

Ca /calmodulin-binding sequence, and the autoinhibitory segment is displaced from the
catalytic core. This allows binding o f the RLC and transfer o f the phosphate from ATP
to RLC on Ser 19 which results in cross-bridge cycling and the production o f contractile
force (reviewed by 4,5, 6 ,7). Smooth muscle MLC kinase has a different catalytic
specificity than the skeletal muscle form, and in smooth muscle, MLC phosphorylation is
sufficient to initiate contraction ( 8 ), but studies show that the regulation o f contraction
can not be fully explained by Ca2+-activation o f MLC kinase in all smooth muscle types
(9, 10 and reviewed by 4).
A second smooth muscle regulatory system involving sensitization o f contractile
proteins to Ca2+ is now known to be responsible for an elevation in the degree of
contractile force without further increases in [Ca2+]j, and is termed Ca2+-sensitization (6 ,
5, 11). Proof o f the existence o f Ca2+-sensitization was found in studies utilizing
permeabilized smooth muscle cells, which allow the [Ca2+]j to be held at a constant level.
Studies demonstrated that in the presence o f GTP, contractions could be elicited by
agonists at a constant [Ca2+]i (5,12, 13). Therefore, smooth muscle contraction is
dependent not only on [Ca2+]; and the Ca2+/calmodulin-dependent activation o f MLC
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kinase, but also the Ca2+-sensitivity (elevated degree o f contractile force per unit of
[Ca2+]; o f the contractile apparatus) ( 6 , 5, 11,14).

II.3 Calcium Sensitization in Smooth Muscle
There are two generally accepted mechanisms proposed to govern Ca2+sensitization; regulation o f the thin filament-associated proteins, called thin filament
regulation, and regulation o f MLC phosphorylation primarily via alterations in MLC
phosphatase activity. Thin filament regulation suggests that the cross-bridges between
actin and myosin are regulated by thin filament-associated proteins, such as calponin and
caldesmon. Many o f these studies investigate the inhibition o f actin and myosin
interactions and the effects of thin filament-associated proteins on cross-bridge cycling
rates. Data that support this hypothesis include studies that indicate cross-bridge cycling
rates can vary without concomitant changes in MLC phosphorylation, and studies
showing a dissociation between tension (force) and MLC phosphorylation (15,16 and
reviewed by 17; 18, 19). Data suggest that caldesmon tethers and aligns actin and
myosin, but interferes with their interaction until contraction is elicited by receptor
agonists. Other studies show that calponin participates in the signaling pathway of
protein kinase C (PKC) activation (see Fig 1, page 7 for pathway). A complicating factor
in thin filament regulation research is the issue o f significant variances in results from
different species and tissues. Studies also find opposing results with different agonists
(reviewed by 2 0 ).
Although the precise signaling mechanisms which govern Ca2+-sensitization are
not known, many proposed mechanisms converge on the regulation o f MLC phosphatase
rather than on the regulation o f thin filaments. Furthermore, some o f the signaling
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molecules involved in Ca -sensitization due to MLC phosphatase inhibition have been
linked to pathophysiological conditions such as high blood pressure and cerebral
vasospasm and could be targets for therapeutic strategies (reviewed by 21 ).
Ca2+-sensitization due to MLC phosphatase inhibition is produced by agents that
activate G-protein-coupled receptors, phorbol esters, and arachidonic acid. Activation of
2_|_

. . .

.

G protein-coupled receptors, by Ca -sensitizing agonists, results in the activation of
phospholipase CP (PLC). PLC mediates the hydrolysis o f phosphatidylinositol-4,5-bisphosphate (PIP 2) into inositol-1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol (DAG).
IP 3 causes the release o f calcium from the sarcoplasmic reticulum (SR) which results in
an increase in [Ca2+]i and activation o f M LC kinase. D A G and C a2+ activate protein
kinase C (PKC) (Fig 1).

'f i c a p
IPs

MLCK
MLC;

RELAX

PL

P IP

R h o A /G D P

DAG

c o h tm c t

MLCP

PKC
RhoA/GXP

C P I-1 7
ROK

94-

F igure 1. M odel o f G protein-activated Ca -sensitization.

0+
PKC plays a role in the Ca -sensitization elicited by G-protein coupled receptor
activation by decreasing MLC phosphatase activity (reviewed by 22). PKC inhibits
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MLC phosphatase by activating the 17 kDa protein kinase C-potentiated inhibitory
38

protein (CPI-17) by phosphorylating it on threonine . MLC phosphatase is composed of
three subunits; a 37 kDa catalytic subunit o f protein phosphatase type 15 (PPlc), a large
130 kDa myosin binding or targeting subunit (MYPT1), and a 20 kDa noncatalytic
subunit o f unknown function. Activated CPI-17 phosphorylates the PP1 subunit of
MLCP which results in dissociation of the MLC phosphatase subunits and inactivation of
the enzyme (23, 24, 25, 26 and reviewed by 21). Studies indicate that PKC may play a
lesser role than the protein RhoA in agonist-induced Ca -sensitization (reviewed by 1).

II.4 RhoA Function and Regulation
RhoA is a member o f the Ras superfamily o f small monomeric GTPases. RhoA
functions as a molecular switch as it cycles between an inactive, GDP-bound state and an
active GTP-bound state. RhoA is cyclically regulated such that in resting cells RhoA is
bound to Rho guanosine nucleotide dissociation inhibitor (RhoGDI). RhoGDI inhibits
the exchange of GTP for GDP thereby inhibiting RhoA from becoming active.
RhoA can be activated by several G-proteins such as G a ^ n , G aq and G a ;_2
depending on the cell type and agonist involved (27, 28 and reviewed by 21). When a
cell is stimulated, guanine nucleotide exchange factors (GEFs) stimulate the exchange of
GTP for GDP on RhoA resulting in the targeting o f GTP-RhoA to the membrane. When
RhoA has activated its target and is in the GDP-RhoA conformation, RhoGDI binds
GDP-RhoA and extracts it from the cell membrane. Therefore, RhoA cycles from an
inactive, cytosolic RhoGDI-bound form and an activated membrane-bound form. In the
cytosol, the geranyl-geranylated (hydrophibic) tail of RhoA inserts into a hydrophiboc
cavity o f RhoGDI. This binding is reinforced by protein-protein interactions between the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

9

highly conserved GDI-binding site on RhoA and the N-terminus o f RhoGDI (21). RhoA
activity is also regulated by GTPase-activating proteins (GAPs). GAPs accelerate the
intrinsic GTPase o f RhoA, speeding the conversion o f active GTP-RhoA to inactive
GDP-RhoA (1).
RhoA is involved in the regulation o f a number o f cell processes which regulate
cell morphology, cell aggregation, membrane ruffling, stress-fiber formation and focaladhesion formation. In smooth muscle cells, RhoA participates in the regulation o f cell
contraction as a major player in G protein-coupled receptor elicited Ca 2+-sensitization.
The effects o f RhoA are thought to be mediated in large part through its effector ROK
(reviewed by 21 ).

II.5 ROK Function and Regulation
Ttwo isoforms o f ROKhave been identified; ROKa/ROCK II and ROKp/ROCK I
which are 150-160 kDa. ROK isoforms have an N-terminal kinase domain, a central
coiled-coil domain, and a C-terminal pleckstrin homology (PH) domain which has a
cysteine-rich zinc finger insert. The Rho-binding (RB) domain is located in the coiledcoil domain (29). Data suggests that for ROK to become activated by RhoA, GTP-bound
RhoA binds to the Rho binding domain o f ROK. Studies suggest that RhoA binds to the
Rho binding domain o f ROK results in a conformational change in ROK that disrupts the
autoinhibitory interaction between the kinase domain and the catalytic domain (30).
Whereas PKC (via the actions o f CPI-17) inhibits MLC phosphatase by
phosphorylating the PP1 subunit resulting in dissociation of the MLC phosphatase
enzyme, ROK phosphorylates the MYPT1 subunit o f MLC phosphatase inhibiting its
phosphatase activity. This results in an increase in MLC phosphorylation and thus
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contractile force in smooth muscle (Fig 1, page 7) (31,32,33). ROK phosphorylates
MYPT1 at threonine695, serine 849 and threonine 850 (chicken isoform 133kDa) (1). Studies
indicate that phosphorylation o f both threonine 695 and threonine 850 can cause inhibition of
MYPT1 (34 and reviewed by 1). It is therefore unclear which site is responsible for the
Ca2+-sensitizing actions o f ROK.
Furthermore, there is cross talk between RhoA/ROK mediated Ca2+-sensitization
and PKC mediated Ca2+-sensitization. ROK has been shown to activate CPI-17 (the
mediator o f PKC activity). Moreover, ROK can directly phosphorylate MLC at the same
site as MLC kinase. However, studies suggest that ROK mediated inhibition o f MLC
phosphatase is responsible for its Ca2+-sensitizing actions (reviewed by 1).
ROK (a/ II) has been shown to contribute to vascular tone, is upregulated in
hypertension, and plays a role in cytoskeletal reorganization such as stress fiber
formation (35 reviewed by 1). ROK is known to play a major role in the Ca2+sensitization elicited by a variety of receptor agonists. Interestingly, a recent study
suggests that ROK inhibition by HA-1077 and Y27632 results in the inhibition K*induced force (36).

II.6 KCl-induced Calcium Sensitizaton
K+-stimulation (KC1) o f smooth muscle causes depolarization o f the cell
membrane. This results in opening o f voltage-gated Ca2+ channels and an increase in
2+
[Ca ]; and muscle contraction. Therefore, KC1 is often used to induce contractile protein

activation independently of G protein-coupled receptor activation. Moreover, an increase
in [Ca2+]i is therefore a component o f both K+-depolarization-induced contraction and G
protein-coupled receptor-elicited contraction.

1
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The degree o f Ca -sensitization produced by a particular stimulus is based on the
steepness o f the resulting force-[Ca2+]i relationship as compared to that produced upon
stimulation with KC1 (reviewed by 37). However, Yangisawa and Okada proposed that
KCl itself can produce an increase in the Ca2+-sensitivity o f arteries (38). A very recent
study also suggests that ROK plays a role in the sustained phase o f KCl-induced
contractions (36).
This hypothesis is supported by work from our laboratory showing that KClinduced contraction can be desensitized following an episode o f maximal receptor
activation, termed non-neuronal cell memory (39,40). This means that if arteries are
contracted with a high concentration o f an a-adrenergic agonist, the force (but not
calcium) produced in a subsequent KCl contraction is inhibited when compared to KCl
contractions in control arteries (that had not been previously contracted). This Ca2+desensitization suggests that the arteries retain a “memory” o f the previous receptor
activation, hence the name non-neuronal cell memory. Though the signaling pathway
responsibly for non-neuronal call memory remains to be determined, our laboratory also
'74 -

showed that the degree o f Ca -sensitivity for both KCl and receptor agonists (the degree
'y

I

of force produced for a given [Ca ]j), is dependent on the history o f receptor activation
(41). The finding that both G protein-coupled receptor-elicited contractions and KCl
contractions can be desensitized could suggest a common pathway for Ca 2+-sensitization.
Furthermore, treatment o f arteries with selective ROK inhibitors results in a
reduction o f KCl-induced force and MLC phosphorylation without a reduction in [Ca2+];
that mimics the desensitized KCl response produced with non-neuronal cell memory.
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These data support a role for ROK activation in KCl-induced contraction and suggest that
inhibition of ROK activation could play a role in non-neuronal cell memory.
KCl contractions consist o f a rapid rise in force peaking in -15 seconds, termed
the peak phase, and a slower rise to plateau (-3.5 min.), termed the tonic phase. Data
from our laboratory indicate that the tonic phase o f KCl-induced force is inhibited by the
ROK inhibitor Y-27632 without causing an inhibition o f intracellular Ca2+, suggesting
that ROK-induced Ca2+-sensitization plays a role in the maintenance o f force elicited by
KCl in vascular smooth muscle. The precise signaling mechanisms involved in KClinduced stimulation of vascular smooth muscle have not been fully resolved.
Ca2+-sensitization involves the coordination o f complex signal transduction events
from the plasma membrane to the contractile apparatus. Receptor agonist stimulation that
causes Ca2+-sensitization has been shown to result in a redistribution o f signaling
molecules to the cell membrane (42). Although KCl appears to cause Ca 2+-sensitization,
whether KCl-induced contractions result in a recruitment of signaling molecules to the
plasma membrane o f smooth muscle cells remains to be determined.

II.7 Cross talk involving Cyclic Nucleotides
Recent studies suggest that there is cross talk between the cyclic nucleotides, their
respective protein kinases and the signaling pathways governing Ca2+-sensitization and
Ca2+-desensitization (reviewed by 43). Smooth muscle relaxation can be achieved in
two ways; one way is by removal of the contractile stimulus which is called passive
relaxation. Active relaxation, however is due to the actions o f cAMP-dependent protein
kinase (PKA) and cGMP-dependent protein kinase (PKG). Studies indicate that cGMP
mediates the relaxing effects of atrial natriuretic peptide and nitric oxide (NO). PKG
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relaxation involves an inhibition o f PLC activation, IP 3 production and intracellular
calcium mobilization (reviewed by 43).
Furthermore, PKG is known to cause Ca2+ desensitization by dephosphorylation
o f myosin light chains (44,45,46,47). Studies suggest that G protein-coupled receptors,
PLC and MLC kinase are substrates for PKA and PKG. Additionally, PKG acting
downstream o f cGMP has been shown to inhibit RhoA-dependent Ca2+-sensitization (48).
74One study suggests that PKG could participate in Ca -desensitization by
phosphorylating active RhoA. PKG phosphorylation o f RhoA results in its removal from
the membrane, increasing its interaction with RhoGDI and stabilizing it in the inactive
form (49). Another study suggests that ROK is a substrate for PKG (22). Though the role
o f cyclic nucleotides in smooth muscle contraction is complex and not fully understood
there is evidence o f cross talk between cyclic nucleotide dependent protein kinases and
Ca2+-sensitization.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

14

CHAPTER III
CAVEOLAE
III.l Defining Caveolae
Caveolae are invaginations o f the plasma membrane found in many cell types,
including smooth muscle cells, hypothesized to participate in clatherin-independent
endocytosis, cholesterol transport and calcium signaling (50,51,52,53 and reviewed by
54). Though historically studied as transporters o f molecules across endothelial cell
membranes, caveolae now are being viewed as a multifunctional membrane system. The
name caveolae intracellularis (little caves) was proposed by Yamada in 1995 to describe
“a small p o c k e t... communicating with the outside o f the cell” in gallbladder cells.
Palade described similar structures in endothelial cells, but because he observed them
shuttling molecules in the cells, he referred to them as plasmalemmal vesicles (55).
Other studies supported Palade’s hypothesis, that these were endocytic vesicles, but little
work was done to determine the role o f these structures in other cell types. The recent
discovery o f the integral caveolar proteins, caveolin, have renewed interest in caveolar
function (56). Current caveolae research focuses on the compartmentalization o f signal
transduction molecules, and the idea that caveolin acts as a scaffold for signaling
pathways by coordinating extracellular stimuli and intracellular effectors (57).
Caveolae can have a variety o f morphological characteristics including a tubular,
vesicular or flat shape and can be either open or closed at the cell surface. In smooth
muscle, caveolae are relatively static structures and usually appear as singular
invaginations in the cell membrane. Caveolae are 50-90 nm concavities along the
longitudinal axis o f smooth muscle cells interspersed with dense bodies (57).
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Biochemical characterization includes resistance to Triton X-100 solubilization at 4°C, a
light buoyant density and enrichment of cholesterol, glycosphingolipids, sphingomyelin,
and glycoslyphosphatidlyinositol-anchored protein (54).

111.2 Caveolins
At least four mammalian isoforms o f caveolin, caveolin-la, -ip , -2 and -3
(22kDa) have been identified.

Studies suggest that there is ubiquitous expression of

each caveolin isoform in smooth muscle, specifically caveolin-1 and -3 are found through
the arterial vasculature. Moreover, caveolin assumes a primarily plasma membrane
distribution in smooth muscle cells (57). Caveolin isoforms interact to form homo- and
hetero-oligomers that are stabilized by and require cholesterol for insertion into lipid
membranes (reviewed by 58). A hydrophobic domain o f 33-amino acids (residues 102134) anchors caveolin to the cell membrane such that both the amino and carboxy
terminals of caveolin are free in the cytosol (53). An N-terminal cytoplasmic region of
caveolin - 1 (residues 61-101) directs the interaction o f caveolins to form hetero- and
homo-oligomers (58). Within this region there is a “scaffolding domain” (residues 82101) that is critical for the regulatory interactions o f caveolin (59). The C-terminal
domain (residues 135-178) acts as a bridge and allows oligomers o f caveolin to interact
with one another (58).

111.3 Caveolae in Signal Transduction
The caveolin scaffolding domain is necessary for the regulatory interaction of
caveolin with many signal transduction molecules. Studies using the caveolin scaffolding
domain have led to the identification of amino acid motifs common to many signaling
molecules. Motifs containing TXTXXXX'T and TX X X X TX X T where T = is an
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aromatic amino acid have been found in many molecules suggested to interact with or
bind to caveolin (57). These motifs have been found in the switch 1 region o f RhoA
(residues 34-42), the catalytic domain of ROK (residues 151-159 and 164-181) and the
catalytic domain o f PKC-a (residues 522-528) (57).
Recent studies have shown caveolae to contain multiple receptors including the padrenergic, inositol trisphosphate (IP 3), muscarinic (M 2), endothelin and epidermal
growth factor (EGF) receptors. Caveolae also contain numerous signal transduction
molecules including G-protein a and p subunits, Src-family tyrosine kinases, protein
kinase C (PKC) isoforms, Ras, calmodulin, and effectors such as mitogen activated
protein (MAP) kinase, endothelial nitric oxide synthase (eNOS), and adenylyl cyclase
(53). L-type Ca

■j,

channels, calreticulin and calsequestrin were found in caveolae-

enriched membranes which suggests a role for caveolae in smooth muscle Ca2+ handling
(60).
Studies involving the cytoplasmic delivery o f a peptide encoding the scaffolding
domain result in functional inactivation o f G-protein a subunits, EGFR and PKC, thereby
suggesting a role for caveolin as a general kinase inhibitor. Other studies indicate that
caveolin does not inactivate Ha-Ras which suggests a role for caveolae as a site for the
coordination of activated proteins in some signaling cascades. Some comparisons have
been made o f the caveolin - 1 scaffolding domain to other modular protein domains, such
as the plekstrin-homology domain. Therefore, there is a general hypothesis that caveolin
acts as “molecular Velcro to nucleate the formation o f signal transduction complexes”
(58).
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Receptor agonist stimulation that causes Ca2+-sensitization has been shown to
result in a redistribution o f receptors for contractile agonists to caveolae (61).
Specifically, muscarinic stimulation o f isolated smooth muscle cells resulted in
significant redistribution o f ROK, RhoA and PK C-a to the cell periphery (62).
Furthermore, the introduction o f a peptide corresponding to the scaffolding domain of
caveolin-1, into the cytosol o f smooth muscle cells, inhibits the translocation o f RhoA
and PKC elicited by receptor agonist stimulation (62). These data suggest that caveolae,
via the scaffolding actions of caveolin- 1, could play a role in coordinating the signals
leading from receptor agonist stimulation to Ca2+-sensitization.

III.4 Caveolae Disruption
It has been shown that cholesterol is necessary for invagination and maintenance
o f caveolae, but a recent study shows that both microtubules and actin filaments also play
a role in regulating the caveolar membrane system (63). The caveolae o f cells incubated
with cytochalasin D, which partially disassembles actin filaments, moved from a
membranous distribution to an accumulation in the center o f the cell. Interestingly, cells
incubated with nocodazole, which depolymerizes microtubules, showed linear arrays of
caveolae at the cell surface (63). These data could suggest different roles for actin
filaments and microtubules in caveolar maintenance.
Furthermore okadaic acid, a protein phosphatase inhibitor, causes internalization
o f caveolae as determined by a decease in the number o f invaginations and an
intracellular accumulation o f vesicles (64,54). This internalization was inhibited by
staurosporine, a kinase inhibitor, suggesting that kinase activity may also be necessary to
maintain the population of caveolae at the cell membrane (64). Studies suggest that the
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membranous location of caveolae is necessary for it to coordinate signals between the
extracellular space and the intracellular environment (62), but the specific effects of
caveolar internalization on ROK-mediated Ca2+-sensitization are not known.
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CHAPTER IV
CONFOCAL MICROSCOPY
IV.l Theory and Uses of Confocal Microscopy
An increase in the use o f fluorescent microscopy in contemporary biology has
revealed the limitations of wide-field (conventional) light microscopy. Light emitted or
scattered by objects out o f the plane o f focus blur the image. One advance that can
partially overcome the problems o f conventional fluorescence microscopy is digital
deconvolution software which can mathematically remove this out o f plane light to
sharpen an image. An alternative solution involves the use o f confocal microscopy.
The light from a point source, which, in the case o f laser scanning confocal
microscopy (LSM) is a laser, is projected onto an object in the plane o f interest. Light
(fluorescence) from the focal plane is projected onto a variable pinhole diaphragm
(which, for these studies, was set at 0.5pm). This light passes through the same objective
used for focusing and then through a tube lens. Therefore, the focused spot on the
specimen and the pinhole are at optically conjugate points. Essentially no light, except
that coming from the plane o f interest in the specimen, can pass through the pinhole and
reach the detector. This virtually eliminates the blurring effect o f out o f plane light seen
in conventional light microscopy.
Two galvanometer mirrors steer the illumination spot over the specimen. The
fluorescence emitted at the focal plane, and light emitted at planes above and below it, is
directed onto a main dichroic mirror that separates the emission fluorescence from the
excitation light. The emission fluorescence is further separated by a series o f dichroic
beam splitters and directed to photomultiplier tubes (PMTs).
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The resolution o f the scanned area is variable (but for this project was set at 512 X
512) and the Z-resolution (0.3 pm), termed the optical section thickness, is determined by
the microscope software and is based on the numerical aperture o f the objective and the
pinhole. In the line scanning mode, the lasers scan one line o f the desired focal area, one
at a time, and the analog signal from the PMTs is converted to a digital signal. This
results in an almost simultaneous image from multiple laser excitations. Control o f the
focus movement (Z axis) allows for a series o f images to be taken and projected as a
three dimensional image, or analyzed as a stack o f images.
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CHAPTER V
SPECIFIC AIMS
The goals o f this project are to investigate the signaling mechanisms leading from
9+
KC1 stimulation to Ca -sensitization in vascular smooth muscle and the mechanisms
involved in the desensitization o f KC1 contractions following an episode o f maximal
receptor activation, termed non-neuronal cell memory. I hypothesize that calcium entry
through L-type calcium channels and Ca2+/calmodulin activation elicited by KC1
stimulation leads to translocation o f ROK to caveolae and subsequent activation by
RhoA. I further hypothesize that Ca2+-desensitization in non-neuronal cell memory o f
vascular smooth muscle involves two aspects o f the RhoA/ROK signaling pathway; an
inhibition in ROK translocation to caveolae and an increase in inactive, GDI-bound,
RhoA possibly due to RhoA phosphorylation and removal from the cell membrane.
Thus, the specific aims o f this project are: (1) Determine the mechanism o f tonic force
maintenance in KC1- induced ROK-mediated Ca2+-sensitization o f arterial muscle; (2)
Determine the mechanism by which force maintenance is down regulated in non
neuronal cell memory.
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CHAPTER VI
MATERIALS AND METHODS
VI. 1 Tissue Preparation
Tissues were prepared as previously described (65). Femoral and renal arteries
from adult New Zealand white rabbits were cleaned o f adhering tissue and stored in cold
(0-4°C) physiological saline solution (PSS). The PSS was composed of, in mM, NaCl
140, KC14.7, MgS 0 4 1.2, CaCh 1.6, NaHP 0 4 1.2, morpholino-propanesulfonic acid
(MOPS) 2.0 (adjusted to pH 7.4), Na 2ethylenediamine tetraacetic acid (EDTA, to chelate
heavy metals) 0.02, and D-glucose 5.6. To produce K+-depolarization, KC1 (110 mM)
was substituted isosmotically for NaCl. High purity water, 17 megaQ distilled and
deionized, was used throughout. The endothelium of each artery was removed by gently
rubbing the intimal surface with a metal rod. Tissues were cut into 3-4 mm wide artery
rings.
Each muscle ring was secured in a tissue bath (Radnoti Glass Technology, Inc.,
Monrovia, CA) between stainless steel wire stirrups attached to a micrometer and
isometric force transducer for, respectively, length adjustments and isometric force
measurements (Model 52, Harvard Apparatus, South Natick, MA). Isometric
contractions were measured as previously described (65). Voltage signals from force
transducers were digitized (CIO-DAS16F, Computer Boards, Middleboro, MA), and
visualized on a computer screen as force (g). Data acquisition and analyses were
accomplished using DasyLab (DasyTec, Amherst, NH) and Microsoft Excel (Microsoft
Corp.)
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VI.2 Isometric Force
Contractile force (F) was measured as previously described (65). Tissues were
allowed to equilibrate for 1 hour at 37°C in PSS with aeration. The muscle length for
which active force was maximum (L0) was determined for each tissue using an
abbreviated length-tension curve and KC1 (110 mM, substituted isosmotically for NaCl)
as the stimulus (66,67). For each preloaded tissue, the degree o f steady-state force (F)
produced at L 0 by incubation in KC1 for 5-10 minutes was equal to the optimal force for
muscle contraction (F0), and subsequent contractions were calculated as F/F0. Bay K8644 (0.56-1 pM), a nifedipine analog that increases the open-state probability o f L-type
2

_j_

voltage-operated Ca

channels, was utilized as a contractile agent in some experiments

(68,69). To produce contraction with Bay K-8644, it was necessary to pre-incubate
femoral arteries with 7.5 mM KC1, a concentration o f KC1 which, alone, did not cause
contraction. Ionomycin (10 pM), a calcium ionophore, and phenylephrine (PE), an aadrenoreceptor agonist, were also used as contractile agents in some experiments. No
further length changes were imposed once L 0 was established. All tissues, except those
contracted using PE, were incubated with 1 pM phentolamine (PT) to block potential aadrenergic receptor activation caused by the release o f norepinephrine from peri-arterial
nerves that may occur upon stimulation with KC1.

VI.3 Myosin Light Chain (MLC) Phosphorylation
The degree of MLC phoshorylation was measured as previously described (65).
Arteries were quick-frozen in an acetone-dry ice slurry, slowly warmed to room
temperature, dried, weighed, and homogenized in 8 M urea, 2% Triton X-100 and 20 mM
dithiothreitol. Isoelectric variants o f the 20 kDa myosin light chains (MLCs) were
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separated by 2-D (IEF/SDS) PAGE followed by Western Blot with visualization using
colloidal gold staining. The relative amounts o f phosphorylated and non-phosphorylated
MLCs were quantified by digital image analysis (Scion Image, NIH).

VI.4 Intracellular Free Calcium
[Ca2+]i was measured in renal arteries as previously described (65). Arterial rings
positioned inside a quartz cuvette housed in a fluorometer (Photon Technology
International, Lawrenceville, NJ) and maintained at 37°C were loaded for 2.5 hours with
Fura-2 (PE3)/AM (~7.5mM) and Pluronic F-127 (0.01% w/v) (TefLabs, Austin, TX) to
enhance solubility. Tissues were then washed for 30 minutes in 3 changes o f PSS. The
fluorescence emission at a wavelength o f 510 nm was collected for alternating excitations
at 340 and 380 nm. The [Ca2+]j signals produced during KCl-induced steady-state
contraction in the absence and presence o f Y-27632 were quantified as the fraction o f the
steady-state value produced during the tonic phase o f the KC1 contraction used for the L 0
determination, and the minimum signal produced in a Ca2+-free solution containing 5
mM EGTA plus 10 pM ionomycin, corrected for background fluorescence. The
background fluorescence was recorded by incubating tissue in a 4 mM M nCb quench
solution containing 10 pM ionomycin.

VI.5 Tissue and Slide Preparation for Colocalization
The extent o f ROK co-localization with caveolin at the plasma membrane of
femoral artery smooth muscle cells was investigated. Femoral artery rings 3-4 mm long
were treated as described in “Tissue Preparation”. No difference in ROK colocalization
to caveolin was identified in stretched (Lo) versus un-stretched (Lz) tissues under basal
conditions (Lo: 24 ± 2%, Lz: 18 ± 2%, n=3, P>0.05) and when stimulated with KC1 for 30
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sec (Lo: 34 ± 2%, Lz: 34 ± 2%, n=3, P>0.05). Un-stretched artery rings, which were
technically easier to fix than stretched tissues, were used for all subsequent histological
studies. Tissues stimulated with KC1 were fixed at 30 sec and 5 min. Colocalization of
ROK and RhoA with caveolin, RhoA with caveolin, and caveolin with the nucleus in
KCl-stimulated tissues was compared to that found in tissues not contracted with KC1
(basal). Tissues stimulated with PE were fixed at 30 sec, 5 and 30 min, following 10 min
PE washout, and at 30 sec and 5 min o f the subsequent KC1 contraction. Colocalization,
o f ROK and RhoA with caveolin, RhoA with caveolin, and caveolin with the nucleus in
PE-stimulated tissues was compared to that found in tissues not contracted with PE
(basal).
Tissues were fixed in 100% methanol at -20°C for 5 minutes and then placed in a
solution containing 5% sucrose for 1 hour. Tissues were rapidly frozen in Optimal
Cutting Temperature (OCT) frozen tissue embedding medium (VWR Scientific) using a
histobath (Histobath2 Low Temperature Freezing Bath, Thermo Shandon Inc., Pittsburg,
PA). Frozen tissues were cut into -1 8 pm thick sections on a cryostat (Microm HM505E,
Richard Allan Scientific, Kalamazoo, MI), and each section was placed onto charged
slides (SuperFrost Plus, Fisher Scientific). Slides were dried for a minimum o f 1 hour
prior to storage at -80°C.

VI.6 Immunohistochemistry
Slides were thawed at room temperature for 30 minutes and washed twice in PSS.
Small wells were created on each slide using an ImmEdge Pen (Vector Labs,
Burlingame, CA). Tissues were permeabilized and blocked in one step using a solution
of 0.1% Triton X-100 and 3% normal goat serum (Vector Labs, Burlingame, CA) in PSS.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

26

The slides were washed twice in PSS and incubated with primary antibodies to ROK
(anti-rock-2, goat polyclonal, Santa Cruz Biosciences, Inc., Santa Cruz, CA), caveolin
(anti-caveolin, rabbit polyclonal, BD Biosciences), RhoA (anti-RhoA, mouse
monoclonal, Santa Cruz Biosciences, Inc., Santa Cruz, CA), or RhoGDI (anti-RhoGDI,
rabbit polyclonal, Santa Cruz Biosciences, Inc., Santa Cruz, CA) for one hour at an
optimized dilution o f 1:50. The anti-caveolin antibody used in this study does not
discriminate between the 3 isoforms o f caveolin. Slides were washed twice in PSS and
incubated with fluorophore-conjugated secondary antibodies (Alexa Fluor 488 donkey
anti-goat, for ROK; Alexa Fluor 594 chicken anti-rabbit, for caveolin and RhoGDI; and
Alexa Flour 488 donkey anti-mouse, for RhoA; Molecular Probes, Inc., Eugene Oregon)
for one hour at an optimized dilution o f 1:200. For nuclear staining, slides were washed
twice in PSS and incubated with a nuclear stain (TO-PRO-1 iodide monomeric cyanine
nucleic acid stain iodide, Molecular Probes, Inc., Eugene Oregon) for 10 minutes at a
dilution o f 1:80,000. Tissue sections were washed a final time and coverslips were
applied with an anti-fading medium (VectaShield Anti-fading Medium, Vector Labs,
Burlingame, CA). Slides were viewed and images recorded using a laser scanning
confocal microscope (Zeiss LSM 510, Carl Zeiss Microscopy, Germany). Each tissue
section was excited with two lasers, Krypton/Argon (488 nm) and Helium/Neonl (543
nm), using a rapid line-scanning protocol for excitation, and emission signals were
collected through, respectively, 505-550 nm band pass and 560 nm long pass emission
filters and quantified using a photomultiplier tube and proprietary software. For display
purposes, a composite image was constructed in which, for example, ROK was green,
caveolin was red and signal overlap (colocalization) was yellow. For RhoA
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colocalization to caveolin, RhoA was green and caveolin was red. For RhoA
colocalization with RhoAGDI, RhoA was green and RhoGDI was red, and for caveolin
colocalization to the nucleus, caveolin was red and the nucleus was green.
Approximately 11 images were recorded in the z-dimension, which constituted
one z-series. Images were taken 0.5 pm apart with a zoom o f 2X on a 100X oil
immersion objective. The pinhole was 0.5 airy units. One slide was randomly selected
for viewing and analyses from each sectioned artery ring. A minimum o f 2 z-series were
recorded for each slide from different areas o f the tissue. Images were exported in an
uncompressed tagged-image format (tif) file and image analysis was conducted using
MetaMorph software (Version 4.6r9, Universal Imaging Corporation).

VI.7 Image Analysis and Data Collection
Five consecutive images selected from two different z-series per slide permitted
10 images to be averaged for each artery ring. MetaMorph software (V4.6r9 Universal
Imaging Corp.) separated each composite image into two images, one for each laser. The
software compared the images, pixel by pixel, and determined the percentage overlap of
the fluorescent signals. For example, in specific aim 1 we tested the hypothesis that KC1
increased the degree o f ROK translocation to caveolae at the plasma membrane, so
colocalization of the two fluorophores was determined as the percentage overlap o f the
ROK signal onto the caveolin signal. RhoA colocalization with caveolin, RhoA
colocalization with RhoGDI, and caveolin colocalization with the nucleus were
determined in the same manner. Colocalization measured for all 10 images was
averaged using a spreadsheet (Excel, Microsoft Corp.) and considered an n o f 1.
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VI.8 Drugs
Nifedipine and trifluoperazine (TFP), okadic acid, phenylephrine and 8 br-cGMP
were from Sigma Corporation. Bay K-8644, Y-27632 and ionomycin were from
Calbiochem Corporation. H A -1077 and GF-109203X were from Alexis Corporation.
Nifedipine, Bay K-8644, 8br-cGMP and ionomycin were dissolved in ethanol. Y-27632,
phenylephrine and okadaic acid were dissolved in water. Ethanol was added at a final
concentration no greater than 0.1%, a concentration that had no effect on KC1- or Bay K8644-induced contractions or on the degree o f ROK co-localization with caveolin.

VI.9 Statistics
The null hypothesis was examined using Students’ t-test (when 2 groups were
compared) or using a one-way analysis o f variance (ANOVA). To determine differences
between groups following ANOVA, the Student-Neuman-Keuls post-hoc test was used.
In all cases, the null hypothesis was rejected at P<0.05. For each study described, the n
value was equal to the number o f rabbits from which arteries were taken.
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CHAPTER VII
RESULTS
VII. 1 Effect of ROK, PKC, and L-type calcium channel inhibitors on KCl-induced
force
A KCl-induced contraction (110 mM KC1 substituted isosmotically for NaCl) of
rabbit femoral and renal artery consisted o f a rapid rise in force that reached a maximum
value within -1 5 sec (Peak, Fig 2A) followed by a slower rise to a sustained level within
~3-5 minutes (Tonic; Fig 2A). To determine the effect o f ROK inhibition on KClinduced contraction, tissues were exposed to two different ROK inhibitors; Y-27632 (1
and 3 pM) or H A -1077 (10 pM), then contracted with KC1. Although peak force was not
affected (Fig 2B), both Y-27632 and HA-1077 strongly inhibited tonic force by over 50%
(Fig 2C).
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ROK inhibitors, Y27632 (Y; 1 and 3 pM)
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PKC has been shown to play a role in receptor agonist-induced Ca2+ sensitization,
so we also investigated the role o f PKC in KCl-induced contraction. GF-109203X, when
used at 1 pM, inhibits conventional and novel isoforms (PKCc,n) o f PKC (32,70,71). GF109203X did not inhibit KCl-induced peak or tonic force (Figs 2B and 2C). These data
suggest that ROK does, but PKCc,n does not, play a role in the maintenance o f KClinduced tonic force in rabbit large arteries.

VII.2 Effect of Y-27632 and nifedipine on KCl-induced force and [Ca2+]j
Inhibition o f KCl-induced tonic force by Y-27632 could be caused by inhibition
o f ROK, or by inhibition of Ca2+ entry caused by a non-specific effect o f the drug on
Ca2+channels. We therefore measured the effect o f Y-27632 on steady-state increases in
force and [Ca2+]i produced by KC1. Tissues were loaded with the Ca2+ indicator, fura-2
(see “Methods”) and contracted with KC1. Y-27632 (1 pM) was added and force and
[Ca2+]i were allowed to reach a new steady-state. The L-type calcium channel inhibitor,
nifedipine (10 nM), was subsequently added to completely relax tissues by causing Ca2+
channel blockade (Figs 3A and 3C). Y-27632 reduced tonic KCl-induced force by nearly
40% (Figs 3A and 3B) but did not alter tonic [Ca2+]i (Figs 3C and 3D). Nifedipine
further reduced tonic force to the basal level (Figs 3A and 3B) and nearly abolished
[Ca2+]i (Fig 3C and 3D). These data indicate that 1 pM Y-27632 does not block KClinduced calcium entry, and suggest that KC1 induces the activation o f ROK.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

31

A. Tr a c i n g

1.

u-

1 .0

N ifedipine

0
o

0

o
o.

0.5

0

0

>

>

‘<4—*

o

o

<

<

o.
0

20

40

0.0

60

T i m e (m i n )

■C . T r a c i n g

O
CO
00

1 .5

tJ-

E

3
ou
0
O

S u mma r
ifedipine
EGTA

1 .0
o

. o

100

50

&
^

o

-

20
Time

40
(min)

KC I
Y-27632
N i f edi pi ne

+
+

+
+

+

Figure 3. Effect of Y-27632 (1 pM) and nifedipine (10 nM) on KCl-induced force (A &
B) and [Ca2+]; (C & D). Typical force and calcium tracings are shown in, respectively, A
& C. Data in B and D are mean ± SE; n=3; * p< 0.05 compared to KCl-induced
responses.

VII.3 Effect of Y-27632 on KC1-, Bay K-8644-, and ionomycin-induced MLC
phosphorylation and force
The level o f MLC phosphorylation basally was 9% ± 1%, and KCl-induced
contraction resulted in an increase in MLC phosphorylation to -37% . Y-27632 (1 pM)
nearly abolished this increase (Fig 4A). We also investigated the effect o f Y-27632 on
responses produced by an agent that selectively activates L-type Ca2+channels to cause
Ca2+ entry and contraction. Bay K-8644 (0.56 pM), a nifedipine analog but Ca2+channel
agonist, produced a slow rise in force that reached a plateau in -2 0 min. Y-27632 (1 pM)
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nearly abolished Bay K-8644-induced steady-state MLC phosphorylation (Fig 4A) and
reduced steady-state force by over 70% (Fig 4B). We next examined the ability o f Y27632 to inhibit responses produced by the Ca2+ ionophore, ionomycin, an agent that can
bypass L-type calcium channels to produce contraction by Ca

entry or release of

intracellular Ca2+. Ionomycin (10 pM) produced a rise in force that reached a plateau in
-6.5 min. Y-27632 (3 pM) nearly abolished ionomycin-induced MLC phosphorylation
(Fig 4A) and force (Fig 4C). The ionophore-dependent transfer o f Ca

'7-4-

ions into smooth

muscle cells elicited by ionomycin has been shown to cause membrane depolarization
and thus force development (72). As seen in Fig 4C, we found that 1 pM nifedipine did
not inhibit 10 pM ionomycin-induced contraction in rabbit femoral artery.
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and Bay K-8644- and ionomycin-induced force (B and C, respectively). Effect o f 1
pM nifedipine on ionomycin-induced force (C). Control tissues were not exposed
to a drug. Data are mean ± SE; n~3-5; * p< 0.05 compared to control.
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VII.4 Time dependent effects of Y27632 and nifedipine on KCl-induced force and
MLC phosphorylation
Basal force and MLC phosphorylation were not affected by either 1 pM Y27632
or 1 pM nifedipine (Fig 5). Whereas nifedipine nearly abolished the KCl-induced
increase in force and phosphorylation at 10 seconds and 1 and 5 minutes o f contraction,
Y27632 did not decrease KCl-induced force and phosphorylation at 10 seconds, but did
inhibit both force and phosphorylation at 1 and 5 minutes o f contraction (Fig 5).
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VII.5 Effect of KC1 and Bay K-8644 on ROK colocalization with caveolin at the cell
periphery
In an image o f an unstained femoral artery, captured using a 40X oil immersion
objective o f a laser scanning confocal microscope (see “Methods”), auto-fluorescence
was evident in the adventitia and intima, shown, respectively, on the upper left and lower
right comers o f the image o f Fig 6A. The media, however, displayed very little auto
fluorescence, although elastic lamina between layers o f smooth muscle cells could be
seen (Fig 6A). Images at 200X used for fluorescence co-localization measurements in
this study were taken from areas of the media between elastic lamina rich in vascular
smooth muscle cells and nearly devoid o f auto-fluorescence.
The secondary antibodies used in this study (see “Methods”), when applied alone
displayed minimal fluorescence when a section o f rabbit femoral artery media was
viewed at 200X between layers o f elastic lamina (Fig 6B). However, vascular smooth
muscle cells were clearly evident in fluorescence confocal images taken from tissues
labeled with ROK and caveolin primary antibodies such that caveolin appeared red (Fig
6C) and ROK appeared green (Fig 6D). Caveolin was localized at the cell periphery, as
expected (Fig 6C), while ROK was distributed throughout the cytosol and at the cell
periphery (Fig 6D). Figures 6C-E are representative images o f our data showing ROK
and caveolin staining. Due the secondary antibodies used, in images showing RhoA
colocalization with caveolin, RhoA appeared as green and caveolin appeared as red. In
images showing colocalization o f RhoA to RhoGDI, RhoA appeared as green and
RhoGDI appeared as red, and in images showing caveolin colocalization with the
nucleus, caveolin appeared as red and the nucleus appeared as green.
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C.

Figure 6. Laser scanning confocal images o f rabbit femoral artery. A) unstained 40X
image showing auto-fluorescence in adventitia (upper left) and intima (lower right). B)
200X image labeled with Alexa Fluor 488 donkey anti-goat, and Alexa Fluor 594 chicken
anti -rabbit 2° antibodies, showing minimal non-specific labeling. C-E) 200X image o f an
artery stimulated for 30” with KC1 double-labeled with anti-ROKa goat polyclonal
antibody (plus Alexa Fluor 488 donkey anti-goat 2°) and anti -caveolin rabbit polyclonal
antibody (plus Alexa Fluor 594 chicken anti-rabbit 2°), as described in “Methods”. Image
E) is a composite o f images C) showing caveolin (red) staining only and D) showing
ROK (green) staining only. The yellow color in “E ” represents ROK colocalization with
caveolin.
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In un-contracted (basal) tissues -18% o f ROK was colocalized with caveolin at
the cell periphery (quantified using MetaMorph software as described in “Methods”, and
visualized graphically as yellow in Fig 6E). The amount o f ROK co-localized with
caveolin at the cell periphery nearly doubled at 30” o f KC1 stimulation (Fig 6A). At 5
min of a KC1 stimulus, the amount o f ROK colocalized with caveolin at the cell periphery
had returned to the basal level (Fig 6A).
Thus, -16% of ROK translocated to caveolae at the smooth muscle cell
membrane early during development o f a KCl-induced contraction (30”) and prior to
development o f the slower component of a KCl-induced contraction (tonic phase) that
was inhibited by the ROK inhibitor, Y-27632 (see Figs 2 and 5). Moreover, an equal
amount o f ROK (-16% ) returned to the cytosol during the tonic phase o f contraction.
These data together indicate that ROK translocation to the periphery o f the cell preceded
the tonic phase o f a KCl-induced contraction but that sustained ROK translocation was
not necessary for the maintenance o f tonic contraction.
The calcium channel agonist, Bay K-8644, like KC1, produced a similar
movement o f ROK to the periphery of vascular smooth muscle cells. The addition o f 7.5
mM KC1 10 min prior to addition o f Bay K-8644, which was needed for Bay K-8644induced contraction in rabbit femoral and renal arteries, did not produce a contraction,
nor did it increase ROK translocation from the cytosol to periphery (basal, Fig 7B,
compared to basal in the absence o f 7.5 mM KC1, shown in Fig 7A). However, at 30 sec
o f stimulation with Bay K-8644, -31% o f ROK was colocalized with caveolin at the cell
periphery (Fig 7B). At 5 min, the percentage o f ROK colocalized with caveolin returned
to the basal level (Fig 7B).
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Figure 7. Percent colocalization o f ROK with caveolin at the cell periphery in
rabbit femoral artery at 30 sec (30”) and 5 min (5’) o f stimulation with KC1 (A)
and 0.56 pM Bay K-8644 (B). Tissues stimulated with Bay K-8644 were exposed
to 7.5 mM KC1, a concentration that alone, did not cause contraction. Basal tissues
were not stimulated. Data are mean ± SE; n=3; * p< 0.05 compared to basal.

VII.6 Effect of nifedipine and trifluoperazine (TFP) on the ability of KC1, Bay K8644 and ionomycin to cause increased ROK colocalization with caveolin at the cell
periphery
Our data show that stimuli that increase [Ca2+]j also cause an increase in the
degree o f ROK translocation to the cell periphery, suggesting that increased [Ca2+]j
causes ROK translocation to caveolin. Thus, we examined whether inhibition o f L-type
voltage-operated Ca2+ channels and Ca2+/calmodulin would inhibit KCl-induced ROK
translocation to the cell periphery. Nifedipine (Fig 8A) abolished the increase in
colocalization o f ROK with caveolin at the cell periphery at 30 sec o f stimulation with
KC1, suggesting that calcium entry through L-type calcium channels plays a role in KC1-
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induced translocation o f ROK. TFP, a Ca2+/calmodulin inhibitor (Fig 8B), also abolished
the increase in colocalization of ROK with caveolin at 30 sec o f stimulation with KC1.
Y-27632 did not inhibit ROK translocation (Fig 8C), suggesting that ROK activation was
not necessary for KCl-induced ROK translocation to the cell periphery.
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femoral artery stimulated for 30 sec (30”) and 5 min (5’) with KC1. Basal tissues were not
stimulated. Data are mean ± SE; n=3; * p< 0.05 compared to basal.

Although 1 pM nifedipine inhibited both KCl-induced (Fig 8A) and Bay K-8644induced (Fig 9) increases in ROK translocation to caveolin at 30 sec, nifedipine did not
inhibit ionomycin-induced ROK translocation (Fig 9). These data, along with our finding
that nifedipine did not inhibit ionomycin-induced early force development (Fig 4C)
suggest that nifedipine-insensitive Ca2+ translocation or release o f intracellular Ca2+ by
ionomycin caused ROK translocation to caveolin. TFP inhibited Bay K-8644 and
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ionomycin induced ROK translocation to caveolin (Fig 9), supporting a role for Ca2+calmodulin in regulation o f ROK translocation.
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sec of stimulation. Data are mean ± SE; n=3; * p< 0.05 compared to basal.

V I I. 7

Nifedipine concentration-dependent inhibition of R O K translocation to

caveolae
If 1 pM nifedipine inhibited KCl-induced ROK translocation to caveolin because
o f inhibition o f Ca2+ entry, then lower nifedipine concentrations that partially inhibit Ca2+
entry should cause partial inhibition o f ROK translocation. This was found to be the case.
Whereas 1 pM abolished the increase in ROK translocation produced by KC1 at 30 sec
(Fig 10, and see Fig 8A), lower nifedipine concentrations known to cause partial
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inhibition o f calcium entry and contraction (69) caused only partial inhibition o f KClinduced ROK translocation to caveolin (Fig 10).

40
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Figure.10. Concentration-dependent inhibition o f ROK translocation to caveolae by the
calcium channel blocker, nifedipine. Data are mean ± SE; n=4; * p< 0.05 compared to
basal. 30 sec KC1 data in the absence o f nifedipine is taken from Fig 6A.

VII.8 Effect of KC1 on RhoA translocation to caveolae
Others have shown that upon stimulation with receptor agonists there is a
translocation o f RhoA to the cell periphery. These studies did not quantify RhoA
movement as colocalization with caveolae, but as increase in RhoA in the cortical region
of the cell (42,21). We determined that in un-contracted (basal) tissues -30% o f RhoA
was colocalized w ith caveolin at the cell periphery, and there was no increase in RhoA

colocalization with caveolin at 30” o f KC1 stimulation (Fig 11). These data suggest a
new model for interaction between RhoA and ROK in which the amount o f RhoA at the
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caveolae basally is sufficient to activate the ROK that translocates there during a KC1
contraction.

40

Figure 11. Percent
colocalization o f RhoA
with caveolin at the cell
periphery in rabbit
femoral artery at 30 sec
o f stimulation with KCI.
Basal tissues were not
stimulated. Data are
mean ± SE; n=3; * p<
0.05 compared to basal.
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VII.9 Effect of non-neuronal cell memory on ROK and RhoA translocation to
caveolae
Previous data from our laboratory shows that rabbit femoral artery muscle can
retain a memory o f previous receptor activation, called non-neuronal cell memory.
Femoral arteries were contracted with a maximum concentration (10'5M) o f the aadrenoreceptor agonist phenylephrine (PE) and relaxed by 10 minute PE washout, which
is sufficient to completely relax the artery. Tonic force and MLC phosphorylation in a
subsequent KCI contraction were reduced by 60 % when compared to tissues not
previously contracted with PE, whereas [Ca2+]; was unchanged (39,40).
In the present study, the colocalization o f ROK and RhoA to caveolin was
investigated during PE stimulation and the subsequent KCI contraction to investigate the
postreceptor signaling mechanisms governing non-neuronal cell memory. ROK
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colocalization to caveolin doubles, from basal levels, at 30 seconds o f PE contraction
(Fig 12A) and remains greater than the basal colocalization level at 5 and 30 minutes of
PE contraction. Upon PE washout and muscle relaxation, the level o f ROK
colocalization to caveolin was reduced to the prestimulus basal level. However, unlike
tissues that were not pretreated with PE that display robust increases in ROK
translocation to caveolin at 30 sec o f KCI stimulation, those pretreated with PE showed
no increase in ROK translocation to caveolin when subsequently stimulated with KCI for
30 sec (Fig 12A).
These data support our hypothesis that tonic force maintenance requires ROK
translocation to caveolin, and suggest that one reason PE-pretreatment inhibits KClinduced force maintenance is that PE-pretreatment inhibits stimulus-induced increases in
ROK translocation to caveolae.
We found that under basal conditions, a high percentage (-30% ) o f the principal
cell activator of ROK, RhoA, is colocalized to caveolin at the cell periphery (Fig 11).
Thus, we also investigated the effect o f PE-pretreatment on RhoA colocalization to
caveolin. Interestingly, RhoA colocalization to caveolin was decreased below the basal
level at 30 minutes o f PE contraction and remained below the basal level during the
subsequent KCI contraction (Fig 12B). These data suggest that another mechanism of
desensitization (reduced force maintenance without reduced increases in [C a2+]i) in non
neuronal cell memory involves decrease in RhoA available for activation o f ROK at
caveolae.
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VII.10 Effect of lower PE concentration and longer washout period on inhibition of
ROK translocation in non-neuronal cell memory
Our laboratory has shown that the degree o f downregulation in non-neuronal
memory depends on the concentration o f PE used during the pretreatment episode, the
duration o f the receptor activation and the duration o f the washout period (41).
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Whereas

lOpM PE pretreatment caused desensitization o f both KCI- and histamine-induced
contractions, an EC50 concentration o f PE (0.1 pM) did not induce desensitization, non
neuronal cell memory, when tissues were subsequently stimulated to contract. The
degree o f desensitization produced after pretreatment with lOpM PE was significantly
weaker in tissues following a PE washout o f 2 hours than those washed for 10 minutes
(41). I therefore tested the hypothesis that pretreatment with 0.1 pM PE or a 2 hour
washout following 10 pM PE pretreatment would not inhibit the colocalization o f ROK
to caveolin in a subsequent KCI contraction. Following pretreatment with 0.1 pM PE,
ROK colocalization to caveolin at 30 seconds o f KCI contraction nearly doubled from
basal levels (Fig 13 A). Also, ROK colocalization to caveolin nearly doubled if the PE
washout time is increased to 2 hours (Fig 13B).
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Figure 13. Percentage colocalization o f ROK to caveolin in non-neuronal cell memory
with lower concentration of PE (0.1 pM; A) and increased washout time (2 hours; B).
Data are mean ± SE; n=3; * p< 0.05 compared to basal.
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Therefore, KCI produced the same degree o f ROK translocation to caveolin at 30
seconds when compared to arteries that were not pretreated if the concentration o f the PE
stimulus was decreased from 10 pM to 0.1 pM, and if the washout time was increased
from 10 minutes to 2 hours.

These data offer further evidence that non-neuronal cell

memory involves the RhoA /ROK signaling pathway.

VII. 11 Effect of 8br-cGMP treatment on ROK and RhoA translocation to caveolin
Our laboratory previously reported that there is a basal level o f vasodilatorstimulated phosphoprotein [VASP(Ser

)] phosphorylation in intact femoral arteries,

which is a measure o f PKG activity. VASP phosphorylation is abolished by 1H[l,2,4]oxadiazolo[4,3-a]quinoxalin-l-one (ODQ) and increased in the presence o f a cellpermeable activator o f PKG, 8br-cGMP (73). Treatment o f arteries with 8br-cGMP also
resulted in a decrease in active force but not [Ca2+]i to subsequent histamine and Bay K8644 contractions in a manner similar to non-neuronal cell memory. The effect o f 100
pM 8br-cGMP treatment on ROK and RhoA colocalization to caveolin was determined
to investigate the role o f PKG activity in non-neuronal cell memory.
While not reducing the degree o f basal ROK colocalized with caveolin, 8brcGMP prevented the increase in ROK colocalization to caveolin produced at 30 seconds
by KCI and PE (Fig 14A) compared to untreated arteries (Fig 7A). Moreover, the level
o f RhoA colocalization to caveolin basally was decreased from -28% to -18% for basal
arteries (Fig 14B).
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We found that neither KCI nor PE produced an increase in RhoA colocalization to
caveolin, from basal levels, at 30 sec of stimulation (Figs 11 and 12B), and in the
presence of 8br-cGMP, neither KCI nor PE produced an increase from the low level
induced by 8br-cGMP alone. These data are similar to that determined following
pretreatment with 10 pM PE (Figs 12A&B), and could suggest either a common
mechanism for desensitization o f the KCI response through convergence o f signaling
pathways, or that PE-induced increases in PKG activity caused non-neuronal cell
memory.

VII.12 Effect of non-neuronal cell memory on RhoA colocalization to RhoGDI
RhoA cycles between the inactive GDP-bound form and the active GTP-bound
form via guanine nucleotide exchange and GTP hydrolysis. The protein RhoGDI retains
RhoA in an inactive state by inhibiting guanine nucleotide exchange and hydrolysis.
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Moreover, RhoGDI extracts Rho proteins from the cell membrane maintaining them as
cytosolic and inactive proteins (74). We found that both treatment with 8br-cGMP and
30 minutes o f 10 pM PE pretreatment reduced the basal amount o f RhoA colocalized to
caveolin (Fig 14B and 12B, respectively). A possible explanation for this reduction in
basal RhoA at the cell periphery is that these stimuli increase the amount o f RhoA bound
to RhoGDI in the cytosol.
We tested this hypothesis and found that there was an increase in the
colocalization o f RhoA with RhoGDI at 30 minutes o f PE contraction and at 30 seconds
o f a subsequent KCI contraction (Fig 15A). These data suggest that an increase in
inactive, GDI-bound RhoA is involved in non-neuronal cell memory. Furthermore, there
is an increase in the colocalization of RhoA with RhoGDI in tissues pretreated with 8BRcGMP (Fig 15B).
Taken together these data suggest that a common component in the mechanism
for downregulation in both non-neuronal cell memory (PE pretreatment) and arteries
pretreated with 8br-cGMP is an inhibition of RhoA activity by the binding o f RhoGDI to
RhoA. Removal of active RhoA from the membrane, as determined by a decrease in
RhoA colocalization to caveolin, in PE and 8br-cGMP pretreated arteries further supports
this idea (Figs 12B and 14B).
Recent studies indicate that 8br-cGMP, via the actions o f PKG, causes Ca2+desensitization by dephosphorylation o f myosin light chains (44,45). Recent data also
suggest that PKG phosphorylates RhoA on Ser188 resulting in its removal from the
membrane and increasing its interaction with RhoGDI (49). Our data demonstrate a
reduction in ROK translocation and reduced RhoA activity by increasing the proportion
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of RhoA in the cytosolic, RhoGDI-bound form, and therefore support the hypothesis that
94-

PKG causes Ca -desensitization.

-A. Non-neuronal cell memory - RhoA to GDI
10 minute washout
with 1pM phentolamine

10uM PE

B. Colocalizaton of RhoA to GDI

Figure 15. Colocalization of
RhoA to RhoGDI in non-neuronal
cell memory (A) and in arteries
treated with 100 jxM 8br-cGMP
(B). Data are mean ± SE; n=3; *
p< 0.05 compared to basal.

8br cGMP

VII.13 Effect of okadaic acid on KCl-induced force and [Ca2+]j
Our laboratory has also shown desensitization o f femoral arteries to KCl-induced
increases in force and [Ca2+]i by pretreatment with known PP1 inhibitors, NaF and
okadaic acid (OA) (75). The mechanism o f PP1 inhibitor desensitization is not known
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but has been hypothesized to involve desensitization o f L-type calcium channels or
proteins associated with the channels (75,76). Others have shown that okadaic acid
induces the removal of caveolae from the cell surface and that caveolae internalization is
a kinase dependent phenomenon (64). It has been reported that translocation o f ROK and
RhoA to the cell membrane is necessary for their Ca2+ sensitizing actions which could
suggest that an intact caveolar membrane at the cell membrane is also necessary for the
coordination of RhoA/ROK signaling.
We found that by 45 minutes, 1 pM okadaic acid abolished the force elicited by
KCI (Fig 16A) and greatly reduced the degree o f KCl-induced [Ca2+]i (16B). Given the
report that okadaic acid leads to reductions in the amount of peripheral caveolae available
for signalosome activity (64), these data suggest that intact caveolae are necessary for
KCl-induced force maintenance. The data also suggest a role for kinase-mediated
caveolar disruption in desensitization o f the KCI response.

A. Force (F /F 0)

B. Intracellular Free [C a

]

LL

0.5

LL

0.0

Basal

15'
KCI

15'

45'
[K C I+ lp M O A ]

ll

15'
45'
[K C I+1pM OA]

Figure 16. Effect o f 1 pM okadaic acid on KCl-induced force (A) and [Ca2+]i (B). Data
are mean ± SE; n=3; * p< 0.05 compared to basal (A) and to 15’(B).
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VII.14 Effect of okadaic acid and sodium fluoride on KCl-induced ROK
colocalization with caveolin at the cell periphery
To investigate the effect o f caveolar disruption on the RhoA/ROK signaling
pathway, arteries were treated with either 10 mM NaF or 1 pM OA, and ROK
colocalization to caveolin was determined. The colocalization o f ROK to caveolin at 30
seconds of KCI contraction was abolished by treatment with either NaF or OA (Fig 17A).

w

Figure 17. Effect o f 1 pM okadaic acid and 10 mM NaF on KCl-induced ROK
colocalization with caveolin at the cell periphery (A) and colocalization o f caveolin with
the nucleus (B). Data are mean ± SE; n=3; * p< 0.05 compared to basal.

To qualify the degree o f caveolar movement away from the peripheral sites
induced by treatment with either NaF or OA, we measured the degree o f colocalization of
caveolin w ith the nucleus. U nder basal conditions, less that 5% o f total cellular caveolin

colocalizes with the nuclear compartment, and following exposure to the protein
phosphatase inhibitors, OA and NaF, this percentage doubled (17B). This increase in
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nuclear caveolin supports the contention that OA and NaF decrease the amount o f
peripheral caveolae by causing caveolar internalization (Fig 17B).

VII.15 Effect of actin filament and microtubule disruption on KCl-induced ROK
colocalization with caveolin at the cell periphery
Recent studies suggest that depolymerization o f microtubules causes non
receptor-dependent contraction o f vascular smooth muscle (77), and others report that
contractions caused by microtubule depolymerization involve ROK-dependent Ca2+sensitization (78,79). It has been hypothesized there is dual control o f caveolae by actin
filaments and microtubules such that microtubule disruption results in an increase in
invagination depth o f caveolae and actin filament disruption results in a decrease in
transportation between the endoplasmic reticulum and caveolae (63). To determine the
role of microtubules and actin filaments in KCl-induced ROK translocation, we
determined ROK colocalization with caveolae in the presence o f the microtubule
depolymerizing agents nocodazole and colchicine and the actin filament disrupting agent
cytochalasin D. Treatment with cytochalasin D (1 pM) reduced the KCl-induced increase
in ROK colocalization to caveolin by -50% . Treatment with colchicine (10 pM) did not
affect ROK translocation, but nocodazole (10 pM) inhibited ROK colocalization with
caveolae by -25% . These data suggest that both actin filaments and microtubules play a
role in ROK signaling, and these data support the hypotheses o f others that caveolae and
thus caveolar signaling is under the dual control o f actin filaments and microtubules (63).
Specifically, our results indicating that cytochalasin D causes a -50% reduction in ROK
translocation, support the hypothesis that transport to caveolae requires intact actin
filaments.
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VII.16 Effect of 8br-cGMP and PE pretreatment on KCl-induced caveolin
colocalization with the nucleus
To investigate the role o f caveolar internalization in non-neuronal cell memory
and 8br-cGMP-induced desensitization o f the KCI responses, arteries were pretreated
with either lOOpM 8br-cGMP or lOpM PE for 30 minutes. The colocalization of
caveolin to the nucleus more than doubled following pretreatment with 8br-cGMP, but
PE pretreatment for 30 minutes did not cause a significant increase in caveolar
colocalization with the nucleus.
These data suggest that non-neuronal cell memory (PE pretreatment) and 8brcGMP pretreatment do not operate by entirely identical mechanisms to cause
desensitization o f a subsequent KCI contraction, but do share two common features. First
is an inhibition o f ROK colocalization to caveolae, and second is a decrease o f RhoA at
caveolae as determined by both a decrease in RhoA colocalization to caveolae and an
increase in RhoA colocalization with R hoG D I.
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CHAPTER VIII
DISCUSSION
Vascular smooth muscle contraction is governed by an increase in [Ca2+]; and by
Ca2+-sensitization (reviewed by 37). Whereas the Ca2+/calmodulin-dependent activation
o f MLC kinase is a well understood mechanism for causing smooth muscle contraction,
the precise signaling mechanisms involved in Ca2+-sensitization have not been entirely
elucidated. The clinical relevance o f study in this field is that many pathophysiological
conditions, including hypertension and vasospasm o f the coronary and cerebral vessels,
have been linked to an abnormal state o f vascular smooth muscle contraction and an
9+

overactivity of pathways leading to Ca -sensitization.
One hypothesis for Ca2+-sensitization o f smooth muscle involves regulation o f the
interaction of actin and myosin by thin filament associated proteins. Though there is
evidence that supports this hypothesis in some tissues, the majority o f proposed
9 -4-

•

■

■

•

•

mechanisms for Ca -sensitization involve regulation o f MLC phosphatase (reviewed by
9+

20, 22). Several studies indicate that the Ca -sensitization elicited by receptor agonists
involves inhibition o f the myosin targeting subunit o f MLC phosphatase (MYPT1) via
the actions o f PKC and RhoA. PKC activates PKC potentiated inhibitory protein (CPI17) which phosphorylates the protein phosphatase (PP1) subunit o f MLC phosphatase
resulting in dissociation and inactivation o f the enzyme. Recent studies suggest,
9_l_

however, that PKC does not play a major role in Ca -sensitization. RhoA activates ROK
which phosphorylates and inhibits MYPT1. Some studies suggest that ROK can also
activate CPI-17 and directly phosphorylate myosin light chains at the same site as MLC
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kinase. It is currently thought that direct phosphorylation of MYPT1 is the primary Ca2+sensitizing action of ROK (reviewed by 22).
K+-depolarization (KCI) o f smooth muscle, like receptor activation, causes an
increase in [Ca2+]i, but KCl-stimulation does not cause activation o f G protein-coupled
receptors. Thus, KCI is used to induce contractile protein activation independently of
plasma membrane receptor activation. Recent studies suggest that KCI can also produce
an increase in the Ca2+-sensitivity of arteries (38, 36). Our laboratory has previously
shown that KCl-induced contraction can be desensitized. Upon pretreatment o f arteries
with receptor agonists, the degree o f force produced for a given KCl-induced increase in
[Ca2+]i can be substantially altered (40,41). This is also true for receptor-induced Ca2+sensitivity (41). Since desensitization o f KCl-induced contractions suggests that the
smooth muscle cells stored information about the previous receptor activation, we termed
this phenomenon non-neuronal cell memory. Moreover, we found that in naive arteries,
receptor agonists cause a greater degree of Ca2+-sensitization than KCI (41).
Thus, receptor- and KCl-induced contractile mechanisms share at least one
9+

feature, namely, the degree o f Ca -sensitivity induced upon muscle stimulation is
dependent on the history of receptor stimulation. We propose that this shared feature
9+
reflects a common subcellular mechanism regulating Ca -sensitivity. The present study
•

•

•

9+

is an investigation o f mechanisms regulating the Ca -sensitization produced by KCI and
the Ca2+-desensitization o f KCl-induced contractions in non-neuronal cell memory.
Y-27632 is known to be a highly selective inhibitor o f ROK. The concentrations
of Y-27632 required for 50% inhibition o f phenylephrine-contracted aorta (ICso) and
50% inhibition o f isolated ROK (Ki) are, respectively, 0.7 pM and ~0.1-0.8 pM
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(80,31,81,82). H A -1077, another potent inhibitor o f ROK, has a Ki o f 2-11 pM for ROK,
and neither Y-27632 nor H A -1077 significantly inhibits MLC kinase or PKCa activities
at the concentrations used in the present study (81,83). We found that tonic force
produced by KCI in rabbit arteries was inhibited -50% by 1 pM Y-27632 and more than
60% by 10 pM H A -1077, whereas early peak force was not affected by either ROK
inhibitor. Likewise, early peak MLC phosphorylation was unaffected by 1 pM Y-27632,
whereas 1 pM nifedipine nearly abolished both peak and tonic force and MLC
phosphorylation.
Given the high selectivity of Y-27632 and HA-1077 for ROK inhibition, these
data suggest that ROK did not participate in early force development, but played an
essential role in the maintenance o f KCl-induced steady-state force. Moreover, KClinduced increases in [Ca2+]i were not affected by 1 pM Y-27632, but MLC
phosphorylation was. These data indicate that at this concentration, Y-27632 did not act
as a Ca2+ channel blocker to reduce MLC phosphorylation and force. The Ca2+ channel
blocker, nifedipine, inhibited both peak and tonic MLC phosphorylation and force,
supporting a role for Ca

94-

in early force development and delayed activation o f ROK

leading to tonic force maintenance.
Although Y-27632 is highly selective for inhibition o f ROK, a recent study
revealed that 1 pM Y-27632 can also inhibit PKC8, a novel PKC isotype (32). However,
PKC8 is also strongly inhibited by 1 pM GF-109203X, a staurosporine analog that is
used to concentration-dependently inhibit conventional and novel isoforms o f PKC
(71,70,32). In the present study, 1 pM GF-109203X had no effect on KCl-induced
contraction (see Figs 2B and 2C). Together, these data support the hypothesis that PKC
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does not play a role in KCl-induced tonic force maintenance, but that a common
mechanism shared by KCI and receptor agonists is activation o f ROK.
To induce Ca2+-sensitization, ROK must interact with the plasma membrane
(reviewed by 21), and recent studies suggest that small plasma membrane invaginations,
named caveolae, are major centers for coordination o f cellular signal transduction.
Caveolae contain multiple receptors, signal transduction molecules, voltage-gated ion
channels, and numerous effectors (reviewed by 54,58,53,57). Caveolins, the structural
proteins o f caveolae, act as scaffolds for assembly and interaction o f signaling molecules
at caveolae (reviewed by 58).
That caveolae are loci for receptor agonist-induced Ca2+-sensitization was
proposed recently (57). Furthermore, it was shown that receptor agonist-stimulation of
smooth muscle causes a redistribution o f RhoA, ROK and PKCa from the cytosol to the
cell periphery (42). The present study extends this model to include K+-depolarization as
a stimulus that also causes ROK translocation to caveolae at the plasma membrane of
rabbit arterial smooth muscle.
In this study, we found that the amount o f ROK colocalized with caveolin at the
cell periphery doubles from basal levels upon contraction with either KCI or the L-type
calcium channel agonist Bay K-8644. Moreover both receptor agonists and KCI cause
increases in [Ca2+]j and our data support the hypothesis that Ca2+plays an essential role in
KCl-induced ROK translocation. This is because the Ca2+ channel blocker, nifedipine,
and the calmodulin blocker, trifluoperazine, when used at concentrations that are known
to inhibit contraction (84), prevented KCl-induced ROK translocation to caveolae.
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The fact that nifedipine concentration-dependently inhibited KCl-induced ROK
9+

translocation further supports a role for Ca in the regulation o f ROK activation and
concomitant force maintenance. Moreover, 1 pM Y-27632 inhibited Bay K-8644- and
calcium ionophore (ionomycin)-induced MLC phosphorylation and force. Nifedipine did
not inhibit ionomycin-induced increases in ROK translocation and force which suggests
that the contraction elicited by ionomycin involved C a2+ entry that was independent o f Ltype calcium channels. Furthermore, the C a2+ entry elicited by ionomycin was sufficient
to cause ROK translocation. Though G proteins have been shown to cause C a2+sensitization, these data strongly support a role for an increase in [Ca2+]j, a common
feature o f both receptor activation and KCI contraction, in the pathways leading to C a2+sensitization.
Receptor agonists produce a greater degree o f Ca2+-sensitization than KCI, and
these data could suggest a mechanism for the observed differences in Ca2+-sensitization.
The differences could involve the activation o f PKC, which plays a role in receptor
agonist-induced Ca2+-sensitization, but which we did not find to participate in KCI9+

induced Ca -sensitization. Furthermore, our data show that 30% o f RhoA is colocalized
with caveolin basally (Fig 11), whereas others suggest that the translocation o f RhoA
elicited by receptor agonists to the cell membrane is required for its Ca2+-sensitizing
actions and that receptor agonists cause an increase in RhoA at the plasma membrane
(42, and reviewed by 1). Taken together these data suggest a novel model for Ca2+activated Ca2+-sensitization, elicited by KCI contraction, that involves Ca2+/cam
dependent ROK translocation to caveolae to be activated by the RhoA already there (Fig
20 ).
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Figure 20. Model o f Ca -activated Ca -sensitization.

Our laboratory has shown that the degree o f force produced for a given KCIinduced increase in [Ca ]i can be substantially altered by the history o f receptor
stimulation. For example, femoral arteries were contracted with a maximum
concentration (10'5M) o f the a-adrenoreceptor agonist phenylephrine (PE) and relaxed by
10 minute PE washout. During a subsequent KCI contraction, the tonic force and
increases MLC phosphorylation, but not increases in[Ca2+], are reduced by 60 % when
compared to nai've tissues not previously contracted with PE (40). We termed this
phenomenon non-neuronal cell memory, because the vascular smooth muscle cells stored
information temporarily about the degree o f prior activation (85). Non-neuronal cell
memory could play a role in maintaining vasodilation o f arteries when factors normally
responsible for relaxing the smooth muscle cells are not functioning. For example, if the
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vascular endothelial cells are damaged and unable to produce nitric oxide to maintain the
proper state o f vasodilation, non-neuronal cell memory could protect the artery from
excess contraction that could deprive the downstream organ or tissues o f blood. Previous
data from our laboratory shows that pretreatment o f arteries with PE reduced the ability
o f histamine to cause a subsequent contraction (41). In this way non-neuronal cell
memory could serve as a protective mechanism, or a redundant system in arteries if the
endothelial-derived vasodilatory apparatus is working properly, so that proper blood flow
is maintained. The precise subcellular mechanism causing non-neuronal cell memory
remains to be elucidated, but this study was designed to investigate the possibility that
Ca2+-desensitization elicited in non-neuronal cell memory involves an inhibition o f the
signaling pathways involved in Ca2+-sensitization.
We found that, unlike control tissues showing a robust increase in ROK
translocation at 30 seconds o f KCl-stimulation, tissues pretreated with PE showed no
increase in ROK translocation to caveolin when subsequently stimulated with KCI for 30
seconds. Moreover, whereas -30% o f RhoA is colocalized to cavelin basally, in tissues
not previously contracted with PE, RhoA colocalization to caveolin was decreased below
the basal level at 30 minutes of PE contraction and remained below the basal level during
the subsequent KCI contraction (Fig 12B). Together these data provide a molecular
explanation for non-neuronal cell memory in vascular smooth muscle. The data suggest
that the inhibition of KCl-induced force maintenance by PE-pretreatment involves both
an inhibition o f the stimulus-induced increases in ROK translocation to caveolae and a
decrease in RhoA available for activation o f ROK at caveolae. Moreover, these data
suggest that inhibition o f the RhoA/ROK system, which has been shown to play a major
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role in Ca2+-sensitization, is part o f the information storage mechanism in non-neuronal
cell memory.
Previously our laboratory reported that non-neuronal memory is reversible, such
that the degree o f downregulation to a subsequent contraction is dependent on the
concentration o f PE used during the pretreatment episode and the duration o f the washout
period (41). Our lab previously showed that a high PE concentration (10 pM) resulted in
inhibition o f histamine-induced force, but a low concentration (1 pM) did not reduce
force when compared to tissues that were not pretreated. Additionally, a PE washout
period longer that 90 minutes, reversed the desensitization induced by PE pretreatment
(41).
In the present study, pretreatment with a sub-maximal concentration o f PE (0.1
pM) and increasing the PE washout time to 2 hours resulted in a doubling o f ROK
colocalization to caveolin at 30 seconds of KCI contraction. Thus, the degree o f KClinduced ROK translocation to caveolin at 30 seconds in naive (those not pretreated) was
the same as pretreated arteries if the concentration o f the PE stimulus was decreased from
lOpM to 0.1 pM, and if the washout time was increased from 10 minutes to 2 hours.
These data demonstrate that non-neuronal cell memory is a reversible phenomenon and
further support a role for the RhoA/ROK pathway in non-neuronal cell memory.
Endothelial nitric oxide (NO) causes relaxation o f vascular smooth muscle and
vasodilation, and its actions are mediated by an increase in cGMP. PKG is known to
mediate the actions o f cGMP (49). PKG causes Ca2+-desensitization by
dephosphorylation o f myosin light chains (44,45,46,47), and recent data also suggest that
PKG phosphorylation o f active RhoA results in its removal from the membrane.
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Phosphorylation o f RhoA increases its interaction with RhoGDI and stabilizes it in the
inactive form (49).
These data show that 8br-cGMP, a cell permeable activator o f PKG, prevented the
increase in ROK colocalization to caveolin produced at 30 seconds by KCI and PE.
Furthermore increased PKG activity resulted in a decrease in the basal level o f RhoA
colocalized with caveolin from -28% to ~18% (Fig 13B). In tissues treated with 8brcGMP there was no increase in RhoA colocalization to caveolae upon stimulation with
KCI or PE. Thus, increased PKG activity not only resulted in an inhibition o f ROK
translocation, but also caused a decrease in active RhoA at the membrane. The similarity
of these data to that determined following PE (10pM) pretreatment could suggest that a
common mechanism for desensitization o f the KCI response, with both PKG activity and
non-neuronal cell memory, is inhibition of the RhoA/ROK signaling pathway.
Furthermore, in arteries treated with 8br-cGMP there was an increase in the
colocalization o f RhoA with RhoGDI. An increase in RhoA and RhoGDI colocalization
was also found in arteries at 30 minutes o f PE contraction and at 30 seconds o f a
subsequent KCI contraction. These data support the work of others which showed that
PKG stabilizes the inactive conformation o f RhoA and suggest that RhoA is similarly
inactivated during non-neuronal cell memory.
Desensitization to KCl-induced increases in force and [Ca2+]i in femoral arteries
is also caused by the PP1 inhibitors such as okadaic acid (OA). Others have shown that
OA treatment results in kinase-dependent caveolae internalization (64). Recent studies
propose caveolae as a site for coordination of signaling pathways, so it is possible that
caveolae disruption could inhibit signaling pathways that utilize caveolae for signal
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coordination. In this study, we found that treatment o f arteries with OA and NaF
abolished the colocalization or ROK to caveolin at 30 seconds o f KC1 contraction
suggesting that PP1 inhibition caused desensitization o f the KC1 response in part through
an alteration of the RhoA/ROK signaling pathway. These data support a role for intact
caveolae in the RhoA/ROK pathway leading to Ca2+-sensitization.
To determine whether PP1 inhibition with OA resulted in internalization of
caveolae, we determined the amount o f caveolin colocalized with the nucleus. The data
revealed that treatment with OA and NaF doubled the amount o f caveolin colocalized
with the nucleus from basal levels.
We also found that increased PKG activity, elicited by 8br-cGMP, increased
caveolin colocalization with the nucleus. Thus, we suggest a novel role for PKG in
caveolar internalization which supports the work of others who propose that caveolar
maintenance is kinase-dependent. PE pretreatment (non-neuronal cell memory) did not
cause caveolar internalization. Thus, our data suggest that inhibition o f the RhoA/ROK
signaling pathway rather than a disruption o f caveolae is the information storage method
utilized in non-neuronal cell memory and not a disruption of caveolae.
A recent study demonstrated that caveolae are also under the dual control o f actin
filaments and microtubules (63). The authors show that microtubules are responsible for
maintaining the depth o f caveolar invagination. They further hypothesize that transport
o f proteins to caveolae is controlled by actin filaments (63). Because in the present study
we found that intact caveolae are necessary for RhoA/ROK-mediated Ca2+-sensitization,
we investigated the role o f cytoskeletal elements on the RhoA/ROK signaling pathway.
The disruption of actin filaments with cytochalasin D decreased ROK translocation at 30
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seconds o f KC1 contraction by -50% . Depolymerization o f microtubules with
nocodazole also decreased ROK translocation. These data support the work o f others
that demonstrates a role for actin fdaments in transporting proteins to caveolae, but our
data also suggest that microtubules play a role in ROK mediated signaling in smooth
muscle.
In summary, we propose a novel model for Ca2+-sensitization. We found that
ROK translocation to caveolae is elicited by KC1. Moreover we found that 30% o f RhoA
is colocalized to caveolin basally, and that PKC does not play a role in KCl-induced tonic
force maintenance. These data when taken together suggest that an increase in [Ca2+];,
9+

which is a component o f receptor activation, causes Ca -sensitization. Furthermore our
novel model o f Ca2+-activated Ca2+-sensitization, suggests two mechanisms for the
difference in the degree of Ca2+-sensitization produced by receptor agonists and KC1.
First we determined that PKC does not play a role in KCl-induced Ca2+-sensitization, and
second we found there is not an increase in RhoA colocalization to caveolin above the
30% there basally.
We also suggest that the information storage method utilized in non-neuronal cell
memory involves an inhibition o f the RhoA/ROK pathway. Specifically, PE
pretreatment causes an inhibition o f ROK translocation to caveolae in the subsequent KC1
contraction and also results in an increase in inactive RhoA. The finding, in this study,
that PKG activation also leads to a similar inhibition o f the RhoA/ROK signaling
pathway suggests a common mechanism for Ca2+-desensitization. The desensitization
elicited by PP1 inhibition involved an internalization o f caveolae and an inhibition of
ROK translocation. These data support the hypothesis that caveolae are loci for signal

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

65

transduction pathways, but also suggests that the membranous location o f caveolae is an
important factor in RhoA/ROK-mediated Ca2+-sensitization. The finding that PKG
activation leads to caveolar internalization supports the hypothesis that caveolar
maintenance is kinase mediated, but the precise signals involved in PKG-mediated
caveolar internalization were not determined.
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CHAPTER IX
CONCLUSION
These data suggest that increases in [Ca2+]i rather than strong membrane
depolarization, per se, caused translocation o f ROK to caveolae. Y-27632 did not prevent
KCl-induced ROK translocation at 30”, but did inhibit KCl-induced tonic (i.e., 5’)
contraction, suggesting that ROK activation may not be required to cause ROK
translocation. Moreover, KCl-induced ROK translocation to the plasma membrane
preceded the ability o f Y-27632 to inhibit force. Thus, we suggest that an increase in
[Ca2+]; can induce Ca2+ sensitization by causing Ca2+-dependent ROK translocation to
caveolae for activation by RhoA that is found there basally.
However, these data do not rule out additional signaling events that may be
coordinated at the cell membrane, such as activation o f ZIP-like kinase (86) which has
been shown cause sustained MLC phosphorylation and force in the face o f temporally
falling [Ca2+]i. Thus, a future direction o f this research could be to investigate the role of
possible downstream effectors o f ROK, and their precise effect on MLC phosphatase and
Ca2+-sensitization in smooth muscle.
Furthermore, receptor agonists produce a greater increase in Ca2+-sensitivity than
KC1 (41). Data suggest that receptor agonists cause stronger increases in ROK activity
through additional translocation o f RhoA to caveolae (reviewed by (21)), or by activating
additional Ca2+-sensitizing mechanisms involving PKC (42, 32) that are independent of
increases in [Ca2+]j (34). Though these data suggest two mechanisms for differences in
the degree o f Ca2+-sensitization elicited by KC1 contractions and receptor agonists, it
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remains to be determined whether these are the only mechanistic differences between
these Ca2+-sensitizing stimuli.
Our laboratory has previously shown that the degree o f Ca2+-sensitization elicited
by both receptor agonists and KC1 is dependent on the history o f receptor activation (non
neuronal cell memory) (41). In this study, our data demonstrate an inhibition o f ROK
translocation to caveolae, and a decrease in RhoA colocalization with caveolin as
mediators o f Ca2+-desensitization. These data suggest that an inhibition o f the
RhoA/ROK signaling pathway is a key to the information storage mechanism elicited in
non-neuronal cell memory and desensitization o f the KC1 response.
Others have shown that PKG activation, can cause Ca2+-desensitization by
dephosphorylation o f myosin light chains and inactivation of RhoA (44,45,49). Our data
support a role for PKG in desensitization o f the KC1 response. The data also demonstrate
that a decrease in RhoA at the caveolae and an increase in RhoA colocalization with
RhoGDI is a common feature in both PKG-mediated desensitization and non-neuronal
cell memory. It remains to be determined if PKG plays a role in non-neuronal cell
memory, but our data do suggest that inhibition o f the RhoA/ROK signaling which leads
to desensitization o f the KC1 response is a convergent point in these two signaling
pathways.
Desensitization to KCl-induced increases in force and [Ca2+]i can also be elicited
by the PP1 inhibitors okadaic acid and NaF. Our data suggests that OA also causes
internalization o f caveolar. These data support the work o f others that indicate that
caveolar maintenance is kinase-mediated. Moreover, these data demonstrate that intact
caveolae are important in ROK-mediated Ca2+-sensitization, which supports the role for
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caveolar as major centers for coordination o f signal transduction cascades in vascular
smooth muscle.
The novel finding that PKG activation results in caveolar internalization supports
the hypothesis that caveolar internalization is kinase-mediated. Also, these data
demonstrates that both non-neuronal cell memory and PKG activation involve an
inhibition o f a common pathway (the RhoA/ROK signaling pathway) though the two
methods o f Ca2+-desensitization vary. Thus, caveolar internalization, due to PKG
activity, may play a role in Ca2+-desensitization but it is only one facet o f Ca2+desensitization.
Our data also demonstrate that an intact cytoskeleton is necessary for Ca2+sensitization. Since disruption o f actin filaments abolished ROK movement, a future
direction of this study could be to investigate the role o f unconventional myosins moving
along actin filaments in the process o f protein translocation. Furthermore, the control of
caveolar invagination, or depth, could be important to various signaling pathways as
many receptors and channels are found there. In some cell types caveolae not only act at
scaffolds at the cell membrane but also act as shuttles between organelles (reviewed by
58, 54). Smooth muscle caveolae are relatively static structures at the membrane, but
there is currently little information regarding the effect o f the maintenance o f caveolar
size and shape on the signaling pathways. Our data suggest that Ca2+ can induce Ca2+sensitization, and it is known that much o f the Ca handling machinery m smooth muscle
cells is located in caveolae, including L-type Ca2+ channels (60). Thus, another future
direction o f this work could be to investigate the role o f caveolar internalization or
disruption on Ca2+ signaling and the Ca2+ channels in smooth muscle.
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In summary, we propose a novel model for Ca2+-sensitization. We conclude that
Ca2+ can induce Ca2+-sensitization by causing Ca2+/cam-dependent ROK translocation to
caveolae and activation o f ROK at the caveolae by the RhoA there basally. We conclude
that the desensitization elicited in non-neuronal cell memory involves both an inhibition
of ROK translocation as well as a decrease in RhoA colocalization with caveolin. We
conclude that PKG-mediated Ca2+-desensitization, though also resulting in inhibition of
the RhoA/ROK signaling in a manner similar to non-neuronal cell memory, involves
internalization of caveolae which is not a component o f non-neuronal cell memory.
Furthermore, caveolar internalization elicited by PP1 inhibition and PKG activation Ca2+desensitizes smooth muscle by inhibiting RhoA/ROK signaling. These data support the
hypothesis that caveolae are centers for signal transduction, and we conclude that
caveolae play a major role in coordinating Ca2+-activated, RhoA/ROK-mediated Ca2+sensitization in arterial smooth muscle.
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